Unraveling the Genetics of Otitis Media: from Mouse to Human and Back Again

Overview

Journal Mamm Genome

Specialty Genetics

Date 2010 Nov 26

PMID 21107580

Citations 33

Authors

Marie S Rye

Mahmood F Bhutta

Michael T Cheeseman

David Burgner

Jenefer M Blackwell

Steve D M Brown

Sarra E Jamieson

Affiliations

Soon will be listed here.

Abstract

Otitis media (OM) is among the most common illnesses of early childhood, characterised by the presence of inflammation in the middle ear cavity. Acute OM and chronic OM with effusion (COME) affect the majority of children by school age and have heritability estimates of 40-70%. However, the majority of genes underlying this susceptibility are, as yet, unidentified. One method of identifying genes and pathways that may contribute to OM susceptibility is to look at mouse mutants displaying a comparable phenotype. Single-gene mouse mutants with OM have identified a number of genes, namely, Eya4, Tlr4, p73, MyD88, Fas, E2f4, Plg, Fbxo11, and Evi1, as potential and biologically relevant candidates for human disease. Recent studies suggest that this "mouse-to-human" approach is likely to yield relevant data, with significant associations reported between polymorphisms at the FBXO11, TLR4, and PAI1 genes and disease in humans. An association between TP73 and chronic rhinosinusitis has also been reported. In addition, the biobanks of available mouse mutants provide a powerful resource for functional studies of loci identified by future genome-wide association studies of OM in humans. Mouse models of OM therefore are an important component of current approaches attempting to understand the complex genetic susceptibility to OM in humans, and which aim to facilitate the development of preventative and therapeutic interventions for this important and common disease.

Citing Articles

Resolution of otitis media in a humanized mouse model.

Son Y, Pak K, Muradagha N, Heo K, Leichtle A, Kurabi A Front Genet. 2022; 13:958540.

PMID: 36437913 PMC: 9682244. DOI: 10.3389/fgene.2022.958540.

Etiology, Diagnosis, Complications, and Management of Acute Otitis Media in Children.

Jamal A, Alsabea A, Tarakmeh M, Safar A Cureus. 2022; 14(8):e28019.

PMID: 36134092 PMC: 9471510. DOI: 10.7759/cureus.28019.

The transcriptional landscape of the cultured murine middle ear epithelium in vitro.

Mulay A, Chowdhury M, James C, Bingle L, Bingle C Biol Open. 2021; 10(4).

PMID: 33913472 PMC: 8084567. DOI: 10.1242/bio.056564.

From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children.

Spoiala E, Stanciu G, Bild V, Ababei D, Gavrilovici C Antibiotics (Basel). 2021; 10(1).

PMID: 33419114 PMC: 7825459. DOI: 10.3390/antibiotics10010052.

Single-Cell Transcriptomes Reveal a Complex Cellular Landscape in the Middle Ear and Differential Capacities for Acute Response to Infection.

Ryan A, Nasamran C, Pak K, Draf C, Fisch K, Webster N Front Genet. 2020; 11:358.

PMID: 32351546 PMC: 7174727. DOI: 10.3389/fgene.2020.00358.

References

Tateossian H, Hardisty-Hughes R, Morse S, Romero M, Hilton H, Dean C . Regulation of TGF-beta signalling by Fbxo11, the gene mutated in the Jeff otitis media mouse mutant. Pathogenetics. 2009; 2(1):5. PMC: 2714483. DOI: 10.1186/1755-8417-2-5. View

Teele D, Klein J, Rosner B . Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis. 1989; 160(1):83-94. DOI: 10.1093/infdis/160.1.83. View

Venter J, Adams M, Myers E, Li P, Mural R, Sutton G . The sequence of the human genome. Science. 2001; 291(5507):1304-51. DOI: 10.1126/science.1058040. View

Brannan C, Copeland N, Jenkins N, Nagata S . Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992; 356(6367):314-7. DOI: 10.1038/356314a0. View

Kalm O, Johnson U, Prellner K . HLA frequency in patients with chronic secretory otitis media. Int J Pediatr Otorhinolaryngol. 1994; 30(2):151-7. DOI: 10.1016/0165-5876(94)90198-8. View

Casselbrant M, Mandel E, Fall P, Rockette H, Kurs-Lasky M, BLUESTONE C . The heritability of otitis media: a twin and triplet study. JAMA. 1999; 282(22):2125-30. DOI: 10.1001/jama.282.22.2125. View

Wiertsema S, Khoo S, Baynam G, Veenhoven R, Laing I, Zielhuis G . Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses. Clin Vaccine Immunol. 2006; 13(8):892-7. PMC: 1539116. DOI: 10.1128/CVI.00100-06. View

Jono H, Shuto T, Xu H, Kai H, Lim D, Gum Jr J . Transforming growth factor-beta -Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J Biol Chem. 2002; 277(47):45547-57. DOI: 10.1074/jbc.M206883200. View

Humbert P, Rogers C, Ganiatsas S, Landsberg R, Trimarchi J, Dandapani S . E2F4 is essential for normal erythrocyte maturation and neonatal viability. Mol Cell. 2000; 6(2):281-91. DOI: 10.1016/s1097-2765(00)00029-0. View

10.

Wiertsema S, Herpers B, Veenhoven R, Salimans M, Ruven H, Sanders E . Functional polymorphisms in the mannan-binding lectin 2 gene: effect on MBL levels and otitis media. J Allergy Clin Immunol. 2006; 117(6):1344-50. DOI: 10.1016/j.jaci.2006.01.031. View

11.

Alpay H, Etem E, Kaygusuz I, Yuce H, Karlidag T, Keles E . Evaluation of the polymorphism in the Toll-like receptor 4 (TLR4) genes of tympanosclerosis patients. Auris Nasus Larynx. 2009; 37(1):29-32. DOI: 10.1016/j.anl.2009.03.001. View

12.

Liao J, Kochilas L, Nowotschin S, Arnold J, Aggarwal V, Epstein J . Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. Hum Mol Genet. 2004; 13(15):1577-85. DOI: 10.1093/hmg/ddh176. View

13.

Kalm O, Johnson U, Prellner K, Ninn K . HLA frequency in patients with recurrent acute otitis media. Arch Otolaryngol Head Neck Surg. 1991; 117(11):1296-9. DOI: 10.1001/archotol.1991.01870230112019. View

14.

Prellner K, HALLBERG T, Kalm O, Mansson B . Recurrent otitis media: genetic immunoglobulin markers in children and their parents. Int J Pediatr Otorhinolaryngol. 1985; 9(3):219-25. DOI: 10.1016/s0165-5876(85)80037-9. View

15.

Moll U, Slade N . p63 and p73: roles in development and tumor formation. Mol Cancer Res. 2004; 2(7):371-86. View

16.

Brown S, Hardisty-Hughes R, Mburu P . Quiet as a mouse: dissecting the molecular and genetic basis of hearing. Nat Rev Genet. 2008; 9(4):277-90. DOI: 10.1038/nrg2309. View

17.

Massa H, Cripps A, Lehmann D . Otitis media: viruses, bacteria, biofilms and vaccines. Med J Aust. 2009; 191(S9):S44-9. PMC: 7168357. DOI: 10.5694/j.1326-5377.2009.tb02926.x. View

18.

Parkinson N, Hardisty-Hughes R, Tateossian H, Tsai H, Brooker D, Morse S . Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media. PLoS Genet. 2006; 2(10):e149. PMC: 1592239. DOI: 10.1371/journal.pgen.0020149. View

19.

Megerian C, Semaan M, Aftab S, Kisley L, Zheng Q, Pawlowski K . A mouse model with postnatal endolymphatic hydrops and hearing loss. Hear Res. 2008; 237(1-2):90-105. PMC: 2858221. DOI: 10.1016/j.heares.2008.01.002. View

20.

Depreux F, Darrow K, Conner D, Eavey R, Liberman M, Seidman C . Eya4-deficient mice are a model for heritable otitis media. J Clin Invest. 2008; 118(2):651-8. PMC: 2213371. DOI: 10.1172/JCI32899. View